|
|
Article: Mount Sinai Presents Trial Findings at 2009 Alzheimer's Association International Conference
- Article from:
- Wireless News
- Article date:
- July 15, 2009
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
Wireless News
07-15-2009
Mount Sinai Presents Trial Findings at 2009 Alzheimer's Association International Conference
Type: News
The results of a preliminary clinical trial suggest that a new Alzheimer's drug from Humanetics Corp. is safe for daily use and that cognitive performance in patients with mild to moderate disease remained stable during the six-week course of the trial, the company announced.
In a release, the company noted:
The lack of decline in cognitive performance was an encouraging finding to be further evaluated in a Phase IIB clinical trial.
Phase IIA clinical findings were presented in Vienna today at the 2009 Alzheimer's Association International Conference on ...